Randomized Clinical Trial
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jul 14, 2014; 20(26): 8709-8716
Published online Jul 14, 2014. doi: 10.3748/wjg.v20.i26.8709
Figure 3
Figure 3 Irritable bowel syndrome-related quality of life score response to probiotic and placebo therapy. Good response was defined as score improvement ≥ 15 points; poor response as score improvement 10-15 points; and non-response as score improvement < 10 points. The number of responders (score increment > 10) was significantly larger in both groups of patients treated with probiotics than in those treated with placebo (χ2 test). IBSQoL: Irritable bowel syndrome-related quality of life.